Literature DB >> 27020272

Commentary to: 'Is neutrophil-lymphocyte ratio associated with the severity of allergic rhinitis in children?' Doi: 10.1007/s00405-015-3819-y.

Satvinder Singh Bakshi1,2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27020272     DOI： 10.1007/s00405-016-3923-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  6 in total

1.  The neutrophil-lymphocyte ratio is not enough to describe inflammatory condition.

Authors:  Sevket Balta; Cengiz Ozturk; Ertugrul Kurtoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-11       Impact factor: 2.503

2.  Assessment of the relationship between neutrophil-lymphocyte ratio and hearing loss of diabetics.

Authors:  Erdim Sertoglu; Metin Uyanik; Huseyin Kayadibi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-04       Impact factor: 2.503

3.  Neutrophil-to-Lymphocyte Ratio Positively Correlates to Age in Healthy Population.

Authors:  Jian Li; Qingyu Chen; Xiaohong Luo; Jun Hong; Kunyi Pan; Xianghua Lin; Xiaoqiang Liu; Lijun Zhou; Han Wang; Ying Xu; Hongyu Li; Chaohui Duan
Journal:  J Clin Lab Anal       Date:  2014-10-02       Impact factor: 2.352

4.  Elevated neutrophil-to-lymphocyte ratio in Bell's palsy and its correlation with facial nerve enhancement on MRI.

Authors:  Rauf Oguzhan Kum; Nurcan Yurtsever Kum; Muge Ozcan; Yavuz Fuat Yilmaz; Volkan Gungor; Adnan Unal; Deniz Sözmen Ciliz
Journal:  Otolaryngol Head Neck Surg       Date:  2014-10-27       Impact factor: 3.497

5.  The efficacy of tonsillectomy in chronic tonsillitis patients as demonstrated by the neutrophil-to-lymphocyte ratio.

Authors:  A Yenigun
Journal:  J Laryngol Otol       Date:  2015-03-20       Impact factor: 1.469

6.  Is neutrophil-lymphocyte ratio associated with the severity of allergic rhinitis in children?

Authors:  Mahmut Dogru; Muhammed Fatih Evcimik; Ahmet Adnan Cirik
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-02       Impact factor: 2.503
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.